Boehringer Ingelheim

Lung model

Biotech

Transpire licenses PDE4 inhibitor for lung disease

Transpire Bio has licensed an inhaled PDE4 inhibitor from China’s Intragrand Pharma as a potential treatment for idiopathic pulmonary fibrosis.

James Waldron Jun 3, 2025 9:45am

Lungs

PureTech's deupirfenidone shows durable effect in IPF study

May 20, 2025 5:15pm

Lungs illustration Image Pixabay

Boehringer's phase 3 lung data get muted response from analysts

May 19, 2025 9:24am

lung cancer

Boehringer flexes staying power of HER2-mutant lung cancer med

Apr 28, 2025 9:00am

Glowing puzzle piece fitting into puzzle

Boehringer slots synthetic lethal program into oncology pipeline

Apr 23, 2025 7:45am

Three blocks displaying from left to right a person a handshake and another person

Boehringer lines up B-cell depletion autoimmune R&D via Cue deal

Apr 15, 2025 4:45am